Comprehensive Breast Care
Bartlett, IL
Joined February 2010
- Tweets563
- Following200
- Followers187
- Likes356
Allergic Reactions Including Anaphylaxis ...
Rare allergic reactions:
cdc.gov/mmwr/volumes/70/wr/m… via @CDCgov
We’ve had baseball hockey college football NFL football Tour de France, baseball. Basketball.
All in the midst of a pandemic.
Has anybody stopped to consider how this was all accomplished? The answer is simple - follow the science.
Bob Maganini retweeted
1) SARS-CoV-2 Vaccines - I promised a Tweetorial and here we go. This is going to be long and nerdy. But I'll make sure it is easy to understand. If you want more details, please just read this: nature.com/articles/s41586-0…
Insurance Coverage after Job Loss — The Importance of the ACA during the Covid-Associated Recession | NEJM nejm.org/doi/full/10.1056/NE…
Bob Maganini retweeted
New study finds Covid19 patients are no longer infectious after 11 days of getting sick even though some may still test positive. The data from Singapore adds to a growing body of evidence showing people don’t transmit the infection once they’re recovered. bloomberg.com/news/articles/…
Bob Maganini retweeted
The bottom line analysis from the Korean CDC demonstrating that those testing positive for SARSCoV2 after recovering from covid WERE NOT infected or contagious. The positive hit on the subsequent PCR test was dead virus and could not replicate in viral cell culture.
Korean CDC analysis of 285/447 (64%) who retested #SARSCoV2 positive post #COVID19
👉Viral cell culture (n=108): 0% pos
👉Contacts traced (n=790): only 3 ill, all w/ other exposures
👉These ppl are not re-infected or still contagious. It's old, dead virus.
bit.ly/3e9DPlv
Bob Maganini retweeted
Our week of celebrations wouldn’t be complete without thanking @robinrobertsscn for 15 amazing years coaching SCN Mock. You’ve been the ❤️ of this program, bringing joy and contagious energy — along with the food and fun! 😁🌟⚖️#ThankYouFriend #BigRobbs #MockaFam #SCNPride – at Illinois, USA
Bob Maganini retweeted
A number of seroprevalence studies (that look for antibodies to covid and assess the overall level of population exposure) have now been completed in both U.S. and abroad, and they suggest that outside of epidemic cities; overal infection rates and exposure remain relatively low.
Bob Maganini retweeted
My Op Ed in today's @WSJ on how we can effectively use antibody (serology) tests for covid19 to inform our health and assess our risk as we start to reopen the economy and re-engage in work and the leisure activities we enjoy. wsj.com/articles/antibody-kn…
Bob Maganini retweeted
As we re-open business and leisure activity we need to watch data closely, define a new normal where we do things we need and enjoy but more safely; with added vigilance. There are ways to reduce risk and restart economy. Thoughtful op ed from @MartyMakary nytimes.com/2020/05/14/opini…
Bob Maganini retweeted
Important finding. It suggests that herd immunity could be achieved at a lower threshold than what's typically assumed, because the most susceptible people are the ones who get infected first. Some of those who remain uninfected do so because they may be less susceptible. 1/2
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold medrxiv.org/cgi/content/shor… #medRxiv
Bob Maganini retweeted
Studies suggests activities held outdoors as temperatures warm pose lower covid risk than those done in confined indoor spaces. As we re-open, states should look to ease rules to allow more recreational, religious, and business activities to occur outside. medrxiv.org/content/10.1101/…
Bob Maganini retweeted
Daily positive cases of covid19 as a percent of total daily tests continues to fall nationally, a very good sign as covid testing expands. Declining positivity could be a leading indicator of an epidemic starting to decline. 10% is still high but it's coming down at a steady pace
Bob Maganini retweeted
Evidence of immunity in those who recovered from covid19.
Assessment of #SARSCoV2 antibody response AND cellular immunity in patients recovered from #COVID19: assays, in N=14, indicate most developed neutralizing Abs and their titers correlate w/ numbers of virus-specific T cells cell.com/action/showPdf?pii=… @ImmunityCP
Bob Maganini retweeted
A big win for patients and the first building block in what will be an improving toolbox for reducing death and disease from covid19. FDA's authorization allows for 5 day use in patients who aren't intubated, which will extend Gilead's supply of the drug. nbcnews.com/health/health-ne…
Bob Maganini retweeted
1/2 This is something we've been discussing for some time: Evidence from China shows while manufacturing has restarted, consumer activity hasn't rebounded. Partly it's reduced consumer confidence, but people are also afraid of viral spread and staying home nytimes.com/2020/04/28/busin…
Bob Maganini retweeted
2/2 This is the outcome we must avoid in the U.S. If we restart economic activity, but we don't substantially reduce viral spread, businesses may reopen, but consumers may be nervous about venturing out and engaging in activities. And our economy is one thats led by the consumer
Bob Maganini retweeted
New: Study of 318 outbreaks in China found transmission occurred out-of-doors in only one, involving just 2 cases. Most occurred in home or public transport. Raises key chance for states to move services outdoors (religious, gym classes, restaurants, etc). medrxiv.org/content/10.1101/…
Bob Maganini retweeted
New: Researchers clone two human blocking monoclonal antibodies using #SARSCoV2 specific memory B cells isolated from patients with #COVID19 that bind and neutralize activity of virus; demonstrating the basis for antibody drugs as potential therapeutics. nature.com/articles/s41423-0…